ADVFN - Advanced Financial Network.
HOME» NASDAQ » M » MDVN Stock Price » MDVN Stock News

Medivation Share News

 Medivation (mm) Stock Price
MDVN Stock Price
 Medivation (mm) Stock Chart
MDVN Stock Chart
 Medivation (mm) Stock News
MDVN Stock News
 Medivation (mm) Company Information
MDVN Company Information
 Medivation (mm) Stock Trades
MDVN Stock Trades

MARKET SNAPSHOT: U.S. Stocks Lapse Into Red; Health Care Weighs

By Kristina Peterson Stocks' modest gains dried up Wednesday afternoon as health-care stocks moved deeper into the red following President Obama's latest call on Congress to pass health-care legislation. The sector, which is a traditional defensive haven, has struggled throughout Wednesday's session, hurt at first by optimism sparked by strong reports on jobs and U.S. service sector activity. But the health-care category's losses piled up recently, following conclusion of the president's latest remarks. The Dow Jones Industrial Average (DJI), which was up more than 60 points at its intraday high, was recently down 22up just two points at 10,407.72. Looking to push the "long and wrenching debate" over health care into its final stages, President Barack Obama asked lawmakers to schedule a vote on overhaul legislation "in the next few weeks." Looking to push the "long and wrenching debate" over health care into its final stages, President Barack Obama asked lawmakers to schedule a vote on overhaul legislation "in the next few weeks." "No matter which approach you favor, I believe the United States Congress owes the American people a final vote on health-care reform," Obama said Wednesday in remarks at the White House. "We have debated this issue thoroughly, not just for a year, but for decades." Investors have fretted that any legislation might hurt the ability of private health-care companies to seek profits. On Wednesday, the S&P 500's health-care sector was off 0.4%, leaving the broader index little changed, up just 0.3%. Its materials sector was its biggest gainer, up 1.4% amid an increase in commodity prices. Headlining Wednesday's economic news, payroll giant Automatic Data Processing reported a fewer-than-expected private-sector job losses. The report is an important precursor to the government's February employment report due Friday morning. Traders' fears of a weather-induced slide in Friday's report faded somewhat following the release of the ADP numbers. Analysts are expecting Friday's report from the government to show a loss of 75,000 jobs from U.S. nonfarm payrolls in February, according to a Dow Jones Newswires survey. "I don't think [the Friday report] is going to be a big market mover unless it's extremely positive or negative," said Jim McDonald, chief investment strategist at Northern Trust Global Investments. "Anything in the middle is going to be considered snow-induced." In other economic news on Wednesday, the Institute for Supply Management said U.S. non-manufacturing activity, a measure of the service sector, expanded at a faster-than-expected pace in February. And the Federal Reserve's beige book of regional economic indicators was consistent with bank officials' recent comments painting a picture of a gradual recovery underway. The Nasdaq Composite (RIXF) fell 0.2%. The Standard & Poor's 500-stock (SPX) index declined 0.1%. Movers Industrial giant Caterpillar Inc. (CAT) rose 0.8% as the economically sensitive company was boosted by the latest round of improving data points. General Electric Co. (GE) rose 0.5%, boosted by the signs of economic growth, along with materials components Alcoa Inc. (AA) and DuPont (DD). Alcoa rose 0.8% and DuPont climbed 0.7%. The Dow was also bolstered by its financial components as Fitch Ratings said U.S. credit card delinquencies declined in the January collection period, though charge-offs spiked. Drug maker Pfizer (PFE) was the Dow's worst component. The stock shed 2.1% after Medivation said its experimental Alzheimer's disease treatment Dimebon, which was in development with Pfizer, failed to show effectiveness in a large late-stage study. The news sent shares of Medivation (MDVN) -- which has no products on the market and isn't a Dow component -- plunging 67% on heavy volume. Novell (NOVL) shares surged 28% to $6.1, topping an offer price announced late Tuesday from hedge fund Elliott Associates and sparking speculation another software company or hedge fund could step in with a higher bid. Overseas, the Greek government announced a new austerity plan Wednesday totaling 4.8 billion ($6.53 billion) to ensure it can meet its deficit-cutting pledge this year, including steep cuts in civil service salaries and entitlements. Greece will also raise its sales tax by two percentage points. Greece's planned measures helped prop up the euro against the dollar, which was also weaker against the yen. In other markets, crude-oil prices climbed above $80 a barrel after the government reported a big jump in oil inventories along with an improvement in demand. Meanwhile, gold futures rose and Treasurys declined, with the 10-year note off 6/32 to yield 3.631%.

Stock News for Medivation (MDVN)
DateTimeHeadline
12/05/201215:02:25FDA Approves Highest Number of New Drugs Since 2004
07/23/201211:14:32With Sales Years Away, Pharmacyclics Rallies on Drug Promise
03/08/201217:15:08US Stocks Rise On Optimism About Greece's Debt Swap
03/08/201209:58:03J&J Study May Support Wider Use Of Prostate Cancer Drug Zytiga
01/17/201208:08:04Medivation, Pfizer Alzheimer's Drug Fails To Meet Study Goals
04/11/201108:30:21Medivation, Pfizer Huntington's Drug Fails To Meet Test Goals
04/14/201012:48:32Baxter Bumps Up Schedule For 2nd Late-Stage Alzheimer's Study
03/03/201016:55:19MARKET SNAPSHOT: U.S. Stocks Shed Early Gains As Health Care...
03/03/201015:59:10MARKET SNAPSHOT: U.S. Stocks Struggle As Health-care Stocks Drop
03/03/201015:21:53MARKET SNAPSHOT: U.S. Stocks Lapse Into Red; Health Care Weighs
03/03/201014:08:04MARKET SNAPSHOT: U.S. Stocks Gain On Jobs, Services Prospects
03/03/201012:16:36MARKET SNAPSHOT: U.S. Stocks Extend Gains Into Fourth Day
03/03/201008:49:15Medivation Plunges As Late-Stage Alzheimer's Studies Fail
03/02/201022:45:02ASIA MARKETS: Japanese Drug Makers Put Up A Fight

Medivation and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad